
The S&P/ASX 200 Index (ASX: XJO) is ending the week in a positive session. In afternoon trade, the benchmark index is up 1.2% to 8,698.9 points.
Four ASX shares that are rising more than most today are listed below. Here’s why they are racing higher:
4DMedical Ltd (ASX: 4DX)
The 4DMedical share price is up 12% to $3.74. This follows news that the respiratory imaging technology provider has signed a commercial agreement with SimonMed Imaging. It is one of the leading outpatient medical imaging providers in the United States. 4DMedical’s CEO and founder, Andreas Fouras, said: “SimonMed is one of the largest and most influential outpatient imaging providers in the United States. Their decision to adopt CT:VQ, moving directly to commercial deployment, is a major milestone for 4DMedical and a strong validation of both our technology and our clinical value. In just months since FDA clearance, we have established CT:VQ across leading Academic Medical Centers and are now extending into large-scale imaging networks. This agreement demonstrates that adoption by world-class clinical innovators is translating directly into commercial uptake across high-volume providers.”
Elsight Ltd (ASX: ELS)
The Elsight share price is up 16% to $7.36. Investors have been buying the global enablement technologies provider’s shares after it received a major follow-on order. Elsight advised that a U.S. based commercial customer in the public safety sector has placed a follow-on order valued at approximately US$2 million (~A$2.8 million). The company’s CEO, Yoav Amitai, said: “A U.S Public safety customer increasing their order within months signals strong conviction, highlighting the Company’s operational validation and commercial traction. Public safety agencies are preparing for scaled BVLOS operations and selecting technology partners that meet the highest standards of reliability and compliance.”
Judo Capital Holdings Ltd (ASX: JDO)
The Judo Capital share price is up 12% to $1.56. This small business lender’s shares are lifting off today after it successfully priced a $750 million capital-relief securitisation transaction backed by small and medium enterprise (SME) business loans. It notes that following the transaction, Judo Capital will generate a significant net interest margin on the underlying business loans without needing to hold capital for these assets. Judo Capital’s CEO, Chris Bayliss, said: “We are very pleased with the strong support received for this transaction from a broad range of domestic and international investors. The transaction strengthens Judo’s CET1 position and increases our flexibility to support continued lending growth, while also improving ROE.”
Northern Star Resources Ltd (ASX: NST)
The Northern Star share price is up over 4% to $19.01. Investors have been buying gold miners today after progress appeared to be made with US-Iran peace talks. This put pressure on oil prices, which has lowered interest rate hike expectations, boosting the allure of gold.
The post Why 4DMedical, Elsight, Judo Capital, and Northern Star shares are racing higher today appeared first on The Motley Fool Australia.
Should you invest $1,000 in 4DMedical right now?
Before you buy 4DMedical shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Why ASX 200 gold stocks like Northern Star, Evolution Mining and Newmont shares look like bargain buys now
- 4DMedical shares jump 11% as investors cheer major US agreement
- Which ASX 200 bank stock is jumping 12% on big news?
- Guess which ASX defence stock is rocketing 17% to a record high on Friday
- Judo upsizes $750m securitisation to boost capital and ROE
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.